FindTrial
Sign In

Effect of GSF and anti-coagulation on pregancy maintaining

Effect of GSF and anti-coagulation on pregancy maintaining

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024892
Enrollment
Unknown
Registered
2019-08-02
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Miscarriage

Interventions

Experimental group:GSF infusion
Control:None

Sponsors

Women's Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Aged less than 40, at least four good quality embryos in at least three fresh or frozen cycles, two high-quality embryos (D3) were transferred with FET cycles, the blood beta HCG was lower than the cut off level (30 IU/L) 13 at 9 days after transfer.

Exclusion criteria

Exclusion criteria: 1. NK cells; 2. anti-nuclear antibodies; 3. ratio of cytokines TNF-alpha/IL 10; 4. anti-cardiolipin antibodies; 5. lupus anticoagulant ratio; 6. complement C3/C4, not including definite autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate;—

Secondary

MeasureTime frame
Live birth rate;—

Countries

China

Contacts

Public ContactWu Wei

Women's Hospital, School of Medicine, Zhejiang University

5513019@zju.edu.cn+86 13738051597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026